XtalPi Holdings Limited (HKG:2228)

Market Cap	26.01B -48.2%
Revenue (ttm)	784.09M -0.3%
Net Income	-243.53M
EPS	-0.06
Shares Out	4.30B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,664,160
Open	5.84
Previous Close	5.86
Day's Range	5.60 - 6.09
52-Week Range	5.60 - 14.28
Beta	1.17
Analysts	Buy
Price Target	9.93 (+64.27%)
Est. Earnings	Nov 19, 2026

About XtalPi Holdings

XtalPi Holdings Limited operates as a research platform company in Mainland China, the United States, and internationally. The company offers XmartChem, an intelligent synthesis workstation which automates the chemical synthesis process; ChemPlus, desktop solid dispensing device; PatSight, an optical chemical structure extraction tool for patents; and XFEP, a software for rapid FEP calculations using cloud computing. It also provides XMolGen, a generative chemistry tool; and drug discovery solutions, such as hit discovery, hit or lead optimizat...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2015
• Employees: 1,623
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2228

Financial Performance

Financial numbers in CNY

Analyst Summary

According to 8 analysts, the average rating for 2228 stock is "Buy." The 12-month stock price target is $9.93, which is an increase of 64.27% from the latest price.

Price Target

$9.93

(64.27% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 23, 2026

Data Sources Report a data error